Categories
Type at least 2 characters to search.
View all results →
Ecron Acunova
About CRO
Clinical CRO providing Phase I-IV clinical trial management, biostatistics, and regulatory services with a focus on Indian and Asian markets.
Technology & Expertise
Ecron Acunova developed capabilities in clinical-study design and conduct, bioavailability and bioequivalence research, bioanalysis, clinical data standardization, biostatistics, and regulatory documentation. Its legacy operations combined clinical facilities and scientific teams with data and analytics support for generic and innovative drug-development programs. Ecron Acunova's capabilities were subsequently consolidated into Navitas Life Sciences, so current platforms, locations, and contracting entities should be confirmed with the successor organization.
Core Services
Core services associated with Ecron Acunova include protocol and study design, Phase I-IV clinical operations, bioavailability and bioequivalence studies, clinical monitoring, bioanalytical testing, data management, biostatistics, statistical reporting, dossier preparation, and regulatory support. The organization also supported development pathways for generic products, including ANDA-related programs, and provided regional execution experience in India and other Asian markets. Current service availability should be verified through Navitas Life Sciences.
Accreditations & Compliance
Ecron Acunova supported regulated clinical and bioanalytical programs using study documentation, controlled procedures, data review, and quality oversight appropriate to the applicable submission pathway. Programs may require ICH GCP, GLP or GCLP, bioequivalence, electronic-record, ethics, privacy, and national regulatory controls depending on scope and facility. Because the Ecron Acunova brand was integrated into Navitas Life Sciences, sponsors should verify the current legal entity, SOP framework, facility approvals, inspection history, and study-specific certifications before engagement.
